Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05590715 · ClinicalTrials.gov registry record
International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
A clinical trial of Autism Spectrum Disorder, sponsored by Stalicla.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 20
- Study locations
NCT05590715: Recruiting study of Autism Spectrum Disorder, sponsored by Stalicla.
NCT05590715 is a study of Autism Spectrum Disorder that is actively recruiting participants, run by Stalicla. The registered enrollment target is 1,500 participants, above the 129-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (1063% higher). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05590715, a study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by Stalicla.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 20
- Study locations
Study Summary
To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication
Primary Outcome
A semi-structured medical questionnaire will be administered to collect clinical (sign and symptoms) and anthropomorphic features.
Conditions Studied
Study Locations (20)
Other
- Hospital General Universitario Dr Balmis - Alicante
- Hospital Clinic of Barcelona - Barcelona
- Hospital Infantil Universitario Nino Jesus (HIUNJS) - Madrid
- Hospital universitario Infanta Leonor - Madrid
- Hospital Universitario Puerta De Hierro Majadahonda - Majadahonda
- Policlina Gipuzkoa - San Sebastián
Florida
- BioPhase Research - Miami
- The Angel Medical Research - Miami Lakes
Queensland
- Children's Health Queensland Hospital and Health Service - South Brisbane
- Mater Misericordiae Limited - South Brisbane
Victoria
- Locuspsych - Melbourne
- Murdoch Children's Research Institute - Parkville
Arizona
- SARRC - Phoenix
California
- California Neuroscience Research - Sherman Oaks
Illinois
- Rush University Medical Center - Chicago
Missouri
- University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2022-10-13 |
| Est. Completion | 2025-12-31 |
What NCT05590715 shows while recruiting
NCT05590715 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 129-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (1063% higher).
The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT05590715 names 20 study sites across 12 states, led by Other, Florida, Queensland.
Frequently Asked Questions
What is clinical trial NCT05590715 about?
NCT05590715 is a clinical study titled "International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder". To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication
What is the current status of trial NCT05590715?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2022-10-13. Estimated completion is 2025-12-31.
What conditions does trial NCT05590715 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder.
Who is sponsoring clinical trial NCT05590715?
This trial is sponsored by Stalicla, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05590715 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Illinois, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05590715's enrollment target sits among peer trials
1,500 1st of 224 higher than 224 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) in Adults With ASD
RECRUITING · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI